Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Fowler

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cutis|February 11, 2009
Clinical safety evaluation of a novel barrier protection creamHerbert B Slade, Joseph Fowler, Barry T Reece, et al.
Dermatology and Therapy|August 31, 2016
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 StudiesLeon Kircik, Joseph Fowler, Jonathan Weiss, et al.
Cutis|December 26, 2006
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitisAdelaide A Hebert, John Koo, Joseph Fowler, et al.
Cutis|March 31, 2009
A new ecamsule-containing SPF 40 sunscreen cream for the prevention of polymorphous light eruption: a double-blind, randomized, controlled study in maximized outdoor conditionsVincent A DeLeo, Scott Clark, Joseph Fowler, et al.
Cutis|February 11, 2009
Clinical efficacy evaluation of a novel barrier protection creamHerbert B Slade, Joseph Fowler, Zoe Diana Draelos, et al.
Journal of Medical Internet Research|June 26, 2013
Collection and visualization of dietary behavior and reasons for eating using TwitterMelanie Hingle, Donella Yoon, Joseph Fowler, et al.
Cutis|December 19, 2015
Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skinZoe D Draelos, Joseph Fowler, Walter G Larsen, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studiesJoseph Fowler, Mark Jackson, Angela Moore, et al.
Journal of Drugs in Dermatology : JDD|June 12, 2014
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosaceaJ Mark Jackson, Joseph Fowler, Angela Moore, et al.
Journal of the American Academy of Dermatology|August 9, 2015
Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United StatesCaroline P Schaefer, Joseph C Cappelleri, Rebecca Cheng, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cutis|February 11, 2009
Clinical safety evaluation of a novel barrier protection creamHerbert B Slade, Joseph Fowler, Barry T Reece, et al.
Dermatology and Therapy|August 31, 2016
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 StudiesLeon Kircik, Joseph Fowler, Jonathan Weiss, et al.
Cutis|December 26, 2006
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitisAdelaide A Hebert, John Koo, Joseph Fowler, et al.
Cutis|March 31, 2009
A new ecamsule-containing SPF 40 sunscreen cream for the prevention of polymorphous light eruption: a double-blind, randomized, controlled study in maximized outdoor conditionsVincent A DeLeo, Scott Clark, Joseph Fowler, et al.
Cutis|February 11, 2009
Clinical efficacy evaluation of a novel barrier protection creamHerbert B Slade, Joseph Fowler, Zoe Diana Draelos, et al.
Journal of Medical Internet Research|June 26, 2013
Collection and visualization of dietary behavior and reasons for eating using TwitterMelanie Hingle, Donella Yoon, Joseph Fowler, et al.
Cutis|December 19, 2015
Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skinZoe D Draelos, Joseph Fowler, Walter G Larsen, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studiesJoseph Fowler, Mark Jackson, Angela Moore, et al.
Journal of Drugs in Dermatology : JDD|June 12, 2014
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosaceaJ Mark Jackson, Joseph Fowler, Angela Moore, et al.
Journal of the American Academy of Dermatology|August 9, 2015
Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United StatesCaroline P Schaefer, Joseph C Cappelleri, Rebecca Cheng, et al.
Pageof 4